1.85

3.35% 0.06

Pre-market: 1.81 -0.04 -2.16%

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $1.85, with a volume of 251.84K. It is up +3.35% in the last 24 hours and down -5.13% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$1.79

Open:

$1.8

24h Volume:

251.84K

Relative Volume:

0.51

Market Cap:

$151.32M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-6.8519

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

+11.45%

1M Performance:

-5.13%

6M Performance:

-2.63%

1Y Performance:

-28.29%

1-Day Range:

$1.785

$1.855

1-Week Range:

$1.58

$1.855

52-Week Range:

$1.54

$2.7155

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1151)

Industry

Medical Instruments & Supplies (63)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	1.85	151.32M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	482.74	175.60B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	198.71	59.07B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	92.54	44.80B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	212.91	31.51B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	79.51	15.75B	3.90B	392.30M	288.10M	1.95

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

08:00 AM

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 - Yahoo Finance

08:00 AM

Apr 13, 2025

Raymond James Financial Inc. Purchases New Shares in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Apr 13, 2025

Apr 03, 2025

Stereotaxis stock hits 52-week low at $1.65 amid market challenges - Investing.com Australia

Apr 03, 2025

Stereotaxis stock hits 52-week low at $1.65 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Has $349,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Apr 02, 2025

Mar 30, 2025

3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025 - MSN

Mar 30, 2025

Mar 29, 2025

Bank of New York Mellon Corp Has $440,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World

Mar 29, 2025

Mar 24, 2025

Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic Surgery - MSN

Mar 24, 2025

Mar 21, 2025

Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now? - MSN

Mar 21, 2025

Mar 20, 2025

What's Going On With Stereotaxis Shares Wednesday?Stereotaxis (AMEX:STXS) - Benzinga

Mar 20, 2025

Mar 19, 2025

Stereotaxis stock holds $5 target, reiterates buy at TD Cowen By Investing.com - Investing.com Canada

Mar 19, 2025

Stereotaxis gains support from NVIDIA for AI robotics - Investing.com

Mar 19, 2025

Stereotaxis Announces Acceptance into NVIDIA Connect Program and Highlights at NVIDIA GTC Conference - Nasdaq

Mar 19, 2025

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewswire

Mar 19, 2025

Q4 Rundown: Gates Industrial Corporation (NYSE:GTES) Vs Other Engineered Components and Systems Stocks - The Globe and Mail

Mar 19, 2025

Mar 14, 2025